Develops innovative alpha radioligand therapies to improve cancer treatment efficacy and safety through a patient-centric approach.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. The company focuses on a patient-centric approach, leveraging deep expertise in cancer biology and infrastructure to design, manufacture, and distribute innovative radioligand therapies for improved efficacy and safety in cancer treatment.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
ARTBIO Management Team
Investors
Alexandria Venture Investments
ARTBIO Valuations & Financials
View real-time NPM data on ARTBIO stock including daily ARTBIO stock price estimates, valuation history, and historical share price information. Access ARTBIO financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track ARTBIO pricing across six independent market signals. Looking for private company due diligence data sources on ARTBIO? Get in touch to learn more.
Similar Companies
like ARTBIO
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Zuma
AI & Machine Learning
Automates leasing, collections, and prospect engagement across the full resident lifecycle.
RecoveryOne
Healthcare & Life Sciences
Digital platform delivering personalized rehabilitation programs with guided exercises and expert support for injury recovery and pain management.
Leaf Logistics
Commerce & Marketplaces
A logistics technology company that facilitates collaboration among shippers, carriers, and brokers to optimize freight scheduling and reduce waste.
Nisos
Cybersecurity
Provides intelligence and security solutions to identify, monitor and respond to cyber threats through advanced analytics and real-time monitoring.
Openprise
Enterprise Software
Transforms GTM data into trusted revenue-ready processes with no code.
Van Leeuwen Ice Cream
Consumer
Creates premium dairy and plant-based frozen desserts with simple ingredients and distinctive flavors.
Beni
Commerce & Marketplaces
Delivers automated donation management and impact tracking for individuals and organizations.
Jetti Resources
Industrials
Develops innovative hydrometallurgical technology to extract copper from low-grade sulfides, enhancing existing heap leaching processes.
FAQ
We have answers
ARTBIO stock does not trade on public stock exchanges. ARTBIO stock is considered a private security and you need to be an accredited investor to trade shares. To invest in ARTBIO stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
ARTBIO Stock does not trade on public stock exchanges. In order to sell ARTBIO shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
ARTBIO does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view ARTBIO share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for ARTBIO stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ARTBIO stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in ARTBIO stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
ARTBIO is a private company and has not had an IPO. There is currently no ARTBIO IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to ARTBIO IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
